EW DELHI, July 4, 2025:
The Supreme Court of India on Friday refused to intervene in a plea by HDFC Bank CEO and MD Sashidhar Jagdishan seeking to quash an FIR registered against him on the basis of a complaint by the Lilavati Kirtilal Mehta Medical Trust, which runs Mumbai’s Lilavati Hospital.

A Bench of Justices PS Narasimha and R. Mahadevan declined to entertain the special leave petition, noting that the case is already scheduled for hearing before the Bombay High Court on July 14.

“In view of the listing of the matter on July 14, there is no occasion for us to entertain the special leave petition,” the Bench observed in its order.

Senior advocate Mukul Rohatgi, appearing for Mr. Jagdishan, described the FIR as “frivolous” and claimed it was an attempt to drag the banker and HDFC Bank into a personal dispute between trustees of the hospital trust.

“I am suffering. The bank is suffering. I want interim protection till the matter is heard,” Mr. Rohatgi told the court, referring to delays caused by the fact that three Benches of the Bombay High Court had recused from the case in June.

Justice Narasimha acknowledged the concerns, stating:

“We sympathise with you... Bench after Bench has recused... But now the case is listed for hearing on July 14.”

The Supreme Court also formally recorded the repeated adjournments that took place last month and expressed its “hope and trust” that the High Court will hear the matter as planned.

Senior advocate A.M. Singhvi led the team of lawyers appearing for the Lilavati Kirtilal Mehta Medical Trust.

The dispute stems from a complaint by the Trust alleging wrongdoing that led to the registration of the FIR against Mr. Jagdishan. While details of the complaint itself remain contested, the bank has maintained that it is being unfairly implicated in internal issues unrelated to its operations.

The Bombay High Court’s scheduled hearing on July 14 will now be the next critical step in deciding whether the FIR will be quashed or allowed to proceed.

The Upcoming IPOs in this week and coming weeks are  Asston Pharmaceuticals, CFF Fluid Control, Smarten Power Systems, Glen Industries, Travel Food Services, Anthem Biosciences, Chemkart India.

The Current active IPO are Crizac, Meta Infotech, Happy Square Outsourcing Services, Cryogenic OGS.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.